SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Felix Achana, Stephanie Hubbard, Alex Sutton, Denise Kendrick, Nicola Cooper, An exploration of synthesis methods in public health evaluations of interventions concludes that the use of modern statistical methods would be beneficial, Journal of Clinical Epidemiology, 2014, 67, 4, 376

    CrossRef

  2. 2
    Bonny Parkinson, Sallie-Anne Pearson, Rosalie Viney, Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique, The European Journal of Health Economics, 2014, 15, 1, 93

    CrossRef

  3. 3
    Sally McClean, Jennifer Gillespie, Lalit Garg, Maria Barton, Bryan Scotney, Ken Kullerton, Using phase-type models to cost stroke patient care across health, social and community services, European Journal of Operational Research, 2014, 236, 1, 190

    CrossRef

  4. 4
    Emilio Alba, Eva Ciruelos, Rafael López, José Manuel López-Vega, Ana Lluch, Miguel Martín, Montserrat Muñoz, Pedro Sánchez-Rovira, Miguel Ángel Seguí, COSTABRAX Working Group, Marta Rubio Liria, Ferran Pérez-Alcántara, Cost–utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain, Expert Review of Pharmacoeconomics & Outcomes Research, 2013, 13, 3, 381

    CrossRef

  5. 5
    Romita Das, Shannon Cope, Mario Ouwens, Pauline Turner, Matthew Howlett, Economic Evaluation of Fulvestrant 500 mg Versus Generic Nonsteroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer in the United Kingdom, Clinical Therapeutics, 2013, 35, 3, 246

    CrossRef

  6. 6
    Malcolm J. Price, Nicky J. Welton, Andrew H. Briggs, A.E. Ades, Model Averaging in the Presence of Structural Uncertainty about Treatment Effects: Influence on Treatment Decision and Expected Value of Information, Value in Health, 2011, 14, 2, 205

    CrossRef

  7. 7
    Malcolm J. Price, Nicky J. Welton, A. E. Ades, Parameterization of treatment effects for meta-analysis in multi-state Markov models, Statistics in Medicine, 2011, 30, 2
  8. 8
    Andrea Manca, Andrew R. Willan, “Lost in Translation”, PharmacoEconomics Italian Research Articles, 2010, 12, 3, 183

    CrossRef

  9. 9
    Elizabeth Stojanovski, Kerrie L. Mengersen, Encyclopedia of Biopharmaceutical Statistics, 2010,

    CrossRef

  10. 10
    Elizabeth Stojanovski, Kerrie L. Mengersen, Encyclopedia of Biopharmaceutical Statistics, 2010,

    CrossRef

  11. 11
    David R. Jones, Jaime L. Peters, Lesley Rushton, Alex J. Sutton, Keith R. Abrams, Interspecies extrapolation in environmental exposure standard setting: A Bayesian synthesis approach, Regulatory Toxicology and Pharmacology, 2009, 53, 3, 217

    CrossRef

  12. You have free access to this content12
    Alexander J. Sutton, Julian P. T. Higgins, Recent developments in meta-analysis, Statistics in Medicine, 2008, 27, 5
  13. 13
    K. Le Lay, E. Myon, S. Hill, L. Riou-Franca, D. Scott, M. Sidhu, D. Dunlop, R. Launois, Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system, The European Journal of Health Economics, 2007, 8, 2, 145

    CrossRef

  14. 14
    Andrea Manca, Andrew R Willan, ???Lost in Translation???, PharmacoEconomics, 2006, 24, 11, 1101

    CrossRef

  15. 15
    N. Demiris, L. D. Sharples, Bayesian evidence synthesis to extrapolate survival estimates in cost-effectiveness studies, Statistics in Medicine, 2006, 25, 11
  16. 16
    A. E. Ades, A. J. Sutton, Multiparameter evidence synthesis in epidemiology and medical decision-making: current approaches, Journal of the Royal Statistical Society: Series A (Statistics in Society), 2006, 169, 1
  17. 17
    Alexander J. Sutton, Nicola J. Cooper, Keith R. Abrams, Paul C. Lambert, David R. Jones, A Bayesian approach to evaluating net clinical benefit allowed for parameter uncertainty, Journal of Clinical Epidemiology, 2005, 58, 1, 26

    CrossRef

  18. 18
    Evidence Synthesis in a Decision Modelling Framework,